XENETIC BIOSCIENCES, INC. Research and Development Expense
XENETIC BIOSCIENCES, INC. (XBIO) reported Research and Development Expense of $552.01 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. research and development expense for the quarter ending 2026-06-30 was $552.01K, a 15.92% decline year-over-year.
- XENETIC BIOSCIENCES, INC. research and development expense for the quarter ending 2026-03-31 was $661.44K, a 24.75% decline year-over-year.
- XENETIC BIOSCIENCES, INC. research and development expense for the quarter ending 2025-12-31 was $773.42K, a 25.79% decline year-over-year.
- XENETIC BIOSCIENCES, INC. research and development expense for the quarter ending 2025-09-30 was $756.48K, a 105.57% increase year-over-year.
- XENETIC BIOSCIENCES, INC. research and development expense for fiscal 2025 was $3.07M, a 6.78% decline from fiscal 2024.
- XENETIC BIOSCIENCES, INC. research and development expense for fiscal 2024 was $3.29M, a 5.91% decline from fiscal 2023.
- XENETIC BIOSCIENCES, INC. research and development expense for fiscal 2023 was $3.49M, a 26.75% decline from fiscal 2022.
- XENETIC BIOSCIENCES, INC. research and development expense for fiscal 2022 was $4.77M, a 50.81% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $552.01K 10-Q · filed 2026-08-06 | $1.21M 10-Q · filed 2026-08-06 | $1.99M derived: sum of 3 quarters · filed 2026-08-06 | $2.74M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $661.44K 10-Q · filed 2026-05-12 | $1.43M derived: sum of 2 quarters · filed 2026-05-12 | $2.19M derived: sum of 3 quarters · filed 2026-05-12 | $2.85M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $773.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.53M derived: sum of 2 quarters · filed 2026-03-12 | $2.19M derived: sum of 3 quarters · filed 2026-08-06 | $3.07M 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $756.48K 10-Q · filed 2025-11-12 | $1.41M derived: sum of 2 quarters · filed 2026-08-06 | $2.29M 10-Q · filed 2025-11-12 | $3.33M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $656.56K 10-Q · filed 2026-08-06 | $1.54M 10-Q · filed 2026-08-06 | $2.58M derived: sum of 3 quarters · filed 2026-08-06 | $2.95M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $879.03K 10-Q · filed 2026-05-12 | $1.92M derived: sum of 2 quarters · filed 2026-05-12 | $2.29M derived: sum of 3 quarters · filed 2026-05-12 | $3.22M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.41M derived: sum of 2 quarters · filed 2026-03-12 | $2.34M derived: sum of 3 quarters · filed 2026-03-12 | $3.29M 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $367.99K 10-Q · filed 2025-11-12 | $1.30M derived: sum of 2 quarters · filed 2025-11-12 | $2.25M 10-Q · filed 2025-11-12 | $3.22M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $933.77K 10-Q · filed 2025-08-12 | $1.88M 10-Q · filed 2025-08-12 | $2.85M derived: sum of 3 quarters · filed 2025-08-12 | $3.87M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $944.32K 10-Q · filed 2025-05-13 | $1.92M derived: sum of 2 quarters · filed 2025-05-13 | $2.94M derived: sum of 3 quarters · filed 2025-05-13 | $3.84M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $975.63K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.00M derived: sum of 2 quarters · filed 2025-03-18 | $2.90M derived: sum of 3 quarters · filed 2025-03-18 | $3.49M 10-K · filed 2025-03-18 | ||
| 2023-09-30 | $1.02M 10-Q · filed 2024-11-12 | $1.92M derived: sum of 2 quarters · filed 2024-11-12 | $2.52M 10-Q · filed 2024-11-12 | $3.71M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $903.24K 10-Q · filed 2024-08-13 | $1.50M 10-Q · filed 2024-08-13 | $2.69M derived: sum of 3 quarters · filed 2024-08-13 | $3.09M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $595.28K 10-Q · filed 2024-05-09 | $1.79M derived: sum of 2 quarters · filed 2024-05-09 | $2.19M derived: sum of 3 quarters · filed 2024-05-09 | $4.26M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.59M derived: sum of 2 quarters · filed 2024-03-21 | $3.67M derived: sum of 3 quarters · filed 2024-03-21 | $4.77M 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $398.80K 10-Q · filed 2023-11-09 | $2.48M derived: sum of 2 quarters · filed 2023-11-09 | $3.58M 10-Q · filed 2023-11-09 | $4.81M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $2.08M 10-Q · filed 2023-08-10 | $3.18M 10-Q · filed 2023-08-10 | $4.41M derived: sum of 3 quarters · filed 2023-08-10 | $5.19M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $1.10M 10-Q · filed 2023-05-11 | $2.33M derived: sum of 2 quarters · filed 2023-05-11 | $3.11M derived: sum of 3 quarters · filed 2023-05-11 | $3.64M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $2.01M derived: sum of 2 quarters · filed 2023-03-22 | $2.53M derived: sum of 3 quarters · filed 2023-03-22 | $3.16M 10-K · filed 2023-03-22 | ||
| 2021-09-30 | $780.15K 10-Q · filed 2022-11-09 | $1.30M derived: sum of 2 quarters · filed 2022-11-09 | $1.93M 10-Q · filed 2022-11-09 | $2.43M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $524.55K 10-Q · filed 2022-08-11 | $1.15M 10-Q · filed 2022-08-11 | $1.65M derived: sum of 3 quarters · filed 2022-08-11 | $2.22M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $629.73K 10-Q · filed 2022-05-12 | $1.12M derived: sum of 2 quarters · filed 2022-05-12 | $1.69M derived: sum of 3 quarters · filed 2022-05-12 | $2.00M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $490.79K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.06M derived: sum of 2 quarters · filed 2022-03-22 | $1.37M derived: sum of 3 quarters · filed 2022-03-22 | $1.73M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $573.06K 10-Q · filed 2021-11-12 | $880.96K derived: sum of 2 quarters · filed 2021-11-12 | $1.24M 10-Q · filed 2021-11-12 | $1.66M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $307.90K 10-Q · filed 2021-08-12 | $667.55K 10-Q · filed 2021-08-12 | $1.08M derived: sum of 3 quarters · filed 2021-08-12 | $4.61M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $359.65K 10-Q · filed 2021-05-11 | $777.05K derived: sum of 2 quarters · filed 2021-05-11 | $4.30M derived: sum of 3 quarters · filed 2021-05-11 | $4.79M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $417.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.94M derived: sum of 2 quarters · filed 2021-03-16 | $4.43M derived: sum of 3 quarters · filed 2021-03-16 | $4.89M 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $3.52M 10-Q · filed 2020-11-12 | $4.01M derived: sum of 2 quarters · filed 2020-11-12 | $4.47M 10-Q · filed 2020-11-12 | $4.99M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $487.52K 10-Q · filed 2020-08-12 | $951.30K 10-Q · filed 2020-08-12 | $1.47M derived: sum of 3 quarters · filed 2020-08-12 | $2.20M derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | $463.78K 10-Q · filed 2020-05-14 | $978.51K derived: sum of 2 quarters · filed 2020-05-14 | $1.71M derived: sum of 3 quarters · filed 2020-05-14 | $2.64M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $514.73K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $1.25M derived: sum of 2 quarters · filed 2020-03-26 | $2.18M derived: sum of 3 quarters · filed 2020-03-26 | $2.88M 10-K · filed 2020-03-26 | ||
| 2018-09-30 | $735.88K 10-Q · filed 2019-11-14 | $1.66M derived: sum of 2 quarters · filed 2019-11-14 | $2.37M 10-Q · filed 2019-11-14 | $3.45M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $927.07K 10-Q · filed 2019-08-14 | $1.63M 10-Q · filed 2019-08-14 | $2.71M derived: sum of 3 quarters · filed 2019-08-14 | $3.60M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $706.27K 10-Q · filed 2019-05-13 | $1.79M derived: sum of 2 quarters · filed 2019-05-13 | $2.67M derived: sum of 3 quarters · filed 2019-05-13 | $3.55M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2017-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.97M derived: sum of 2 quarters · filed 2019-03-29 | $2.84M derived: sum of 3 quarters · filed 2019-03-29 | $4.06M 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $884.80K 10-Q · filed 2018-11-09 | $1.76M derived: sum of 2 quarters · filed 2018-11-09 | $2.98M 10-Q · filed 2018-11-09 | $43.19M derived: sum of 4 quarters · filed 2018-11-09 | ||
| 2017-06-30 | $873.84K 10-Q · filed 2018-08-10 | $2.09M 10-Q · filed 2018-08-10 | $2.09M 10-Q · filed 2017-08-14 | $42.31M derived: sum of 3 quarters · filed 2018-08-10 | $43.20M derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | $1.22M 10-Q · filed 2018-05-15 | $41.43M derived: sum of 2 quarters · filed 2018-05-15 | $42.32M derived: sum of 3 quarters · filed 2018-05-15 | $44.53M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $40.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $41.10M derived: sum of 2 quarters · filed 2018-03-30 | $43.31M derived: sum of 3 quarters · filed 2018-03-30 | $43.74M 10-K · filed 2018-03-30 | ||
| 2016-09-30 | $891.83K 10-Q · filed 2017-11-14 | $3.10M derived: sum of 2 quarters · filed 2017-11-14 | $3.53M 10-Q · filed 2017-11-14 | $4.55M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $2.21M 10-Q · filed 2017-08-14 | $2.63M 10-Q · filed 2017-08-14 | $3.66M derived: sum of 3 quarters · filed 2017-08-14 | $4.48M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $429.28K 10-Q · filed 2017-05-15 | $1.46M derived: sum of 2 quarters · filed 2017-05-15 | $2.27M derived: sum of 3 quarters · filed 2017-05-15 | $2.83M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $1.84M derived: sum of 2 quarters · filed 2017-03-31 | $2.40M derived: sum of 3 quarters · filed 2017-03-31 | $3.43M 10-K · filed 2017-03-31 | ||
| 2015-09-30 | $816.32K 10-Q · filed 2016-11-14 | $1.37M derived: sum of 2 quarters · filed 2016-11-14 | $2.41M 10-Q · filed 2016-11-14 | $5.23M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $555.74K 10-Q · filed 2016-08-15 | $1.59M 10-Q · filed 2016-08-15 | $4.41M derived: sum of 3 quarters · filed 2016-08-15 | $6.32M derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | $1.04M 10-Q · filed 2016-05-16 | $3.86M derived: sum of 2 quarters · filed 2016-05-16 | $5.76M derived: sum of 3 quarters · filed 2016-05-16 | $6.79M derived: sum of 4 quarters · filed 2016-05-16 | ||
| 2014-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.73M derived: sum of 2 quarters · filed 2016-03-30 | $5.76M derived: sum of 3 quarters · filed 2016-03-30 | $6.32M 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $1.91M 10-Q · filed 2015-11-16 | $2.94M derived: sum of 2 quarters · filed 2015-11-16 | $3.50M 10-Q · filed 2015-11-16 | $3.95M derived: sum of 4 quarters · filed 2015-11-16 | ||
| 2014-06-30 | $1.03M 10-Q · filed 2015-08-19 | $1.60M 10-Q · filed 2015-08-19 | $2.04M derived: sum of 3 quarters · filed 2015-08-19 | $3.08M derived: sum of 4 quarters · filed 2015-08-19 | ||
| 2014-03-31 | $564.89K 10-Q · filed 2015-05-20 | $565.90K 10-Q · filed 2014-05-20 | $1.01M derived: sum of 2 quarters · filed 2015-07-20 | $2.05M derived: sum of 3 quarters · filed 2015-07-20 | $3.00M derived: sum of 4 quarters · filed 2015-07-20 | |
| 2013-12-31 | $445.59K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | $1.48M derived: sum of 2 quarters · filed 2015-07-20 | $2.44M derived: sum of 3 quarters · filed 2015-07-20 | $3.06M 10-K · filed 2015-07-20 | ||
| 2013-09-30 | $1.04M 10-Q · filed 2014-11-14 | $1.99M derived: sum of 2 quarters · filed 2014-11-14 | $2.61M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $956.41K 10-Q · filed 2014-08-14 | $1.58M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $622.11K 10-Q · filed 2014-05-20 | |||||
| 2012-12-31 | $1.94M 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |